Creative Biolabs Elevates Precision Diagnostics via Advanced Multiplex Biomarker and Custom LFIA Development Platforms
Creative Biolabs, a global leader in integrated biotechnology solutions, today announced the strategic expansion of its diagnostic development ecosystem. Shirley, New York, United States, March 24, 2026 — By integrating high-throughput multiplex biomarker analysis with rapid… Read More »Creative Biolabs Elevates Precision Diagnostics via Advanced Multiplex Biomarker and Custom LFIA Development Platforms





